MedTrace Logo

The Evaluation of Potential Zika, Chikungunya, and Dengue Infections in Mexico

NCT02831699 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2020-12-17

No results posted yet for this study

Summary

This study will evaluate subjects with fever and/or rash to determine the percentage of those infected by the Zika, Chikungunya, or Dengue virus. The study will also compare the clinical signs, symptoms, and lab abnormalities related to each virus, to better specify each virus's characteristics.

Conditions

  • Zika Virus Disease (Disorder)
  • Dengue
  • Chikungunya

Sponsors & Collaborators

  • Secretaria de Salud, Mexico

    collaborator OTHER_GOV

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • Mexican Emerging Infectious Diseases Clinical Research Network

    lead NETWORK

Principal Investigators

  • Sophia Siddiqui · National Institute of Allergy and Infectious Diseases (NIAID)

  • Guillermo Ruiz-Palacios · Mexican Emerging Infectious Diseases Clinical Research Network

  • Pablo Francisco Belaunzarán Zamudio · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-21
Primary Completion
2019-01-25
Completion
2019-01-25

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02831699 on ClinicalTrials.gov